While every industry must deal with FCPA and anti-corruption compliance, the pharmaceutical industry is particularly vulnerable to being investigated for violations. This conference will provide essential specialised guidance for all those who need to know how to shape an efficient anti-corruption compliance programme to limit marketing and sales risks and maintain compliance controls without putting their company at a disadvantage.